Skip to content

Study on blood kinetics of processed plant powder

Study on blood kinetics of processed plant powder - Study on blood kinetics of processed plant powder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030260
Enrollment
12
Registered
2017-12-05
Start date
2017-12-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

On the day intake of the test food-1 Wash out On the day intake of the test food-2 On the day intake of the test food-2 Wash out On the day intake of the test food-1

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Age: 40 and over, below 60. 2)Sex: healthy Japanese males and females who do not suffer from any illness.

Exclusion criteria

Exclusion criteria: 1)Currently in treatment with medication or seeing a doctor for treatment. 2)Previous history of hepatic disorder, severe kidney, endocrine, cardiovascular, gastrointestinal, pulmonary, hematological, or metabolic disorder, or a complication of these. 3)Pregnant, having the potential to become pregnant, or having anemia. 4)Previous history of drug allergy, food allergy, or any abnormality resulted from ingestion of the study plant. 5)Intake of a prescription drug, an over-the-counter drug, a quasi drug, a food product, a health food product, etc. that contains the study plant or a relative plant within the last month. 6)Extreme faddiness. 7)Extremely irregular lifestyle including irregular meal and sleeping patterns. 8)Presence or previous history of mental disorder (depression, etc.). 9)Participation in any other clinical study involving human subjects within 3 months or current participation in any other clinical study involving human subjects. 10)Regular alcohol consumption with an average of 30g/day or more (500 ml of beer, 180 ml of sake), or alcohol consumption of 30g/day or more (500 ml of beer, 180 ml of sake) for at least four days/week. 11)Smoker. 12)Subjects who are deemed to be unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frame
Amount of saponin in plasma

Secondary

MeasureTime frame
Blood test (hematologic, biochemical tests)

Countries

Japan

Contacts

Public ContactOchitani Daisuke

HUMA R&D CORP Clinical Development Division

ochitani@huma-c.co.jp81-3-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026